On July 18, as reported by Korean media, Rural Development Administration (RDA) of Korea found the Soyasaponin content in peanut new seedling is 30times higher than that in ungerminated seeds. Maximally 15.4mg Soyasaponin is in 1g peanut new seedling extractive.

RDA proved the preventive and improving effect of the peanut new seedling extractive for osteoporosis by animal cell test; osteocyte damage ability is restricted for 3.5 times, and bone formation ability is improved 6.1times. Thus, the higher the Soyasaponin content is, the higher the osteocyte activity will be. The seed of peanut new seedling cultivation is the “Xinbaguang” variety in Korea, which is of large grain size, high output and easy cultivation. Test finds the Soyasaponin content is the highest when sprouting for 7~10days and the seedling is about 15cm high.

RDA has applied for patent of “A Production Method of Soyasaponin Substance with Osteoporosis Improvement Function”, and cooperated with enterprises to develop processing food of grains and tea with peanut new seedling extractive as raw materials. The products will be put into market in 2018.

National Academy of Sciences of Korea transferred the patent of peanut new seedling cultivation technology to the company, and the company signed with local growers to plant about 50ha. peanuts.On July 18, as reported by Korean media, Rural Development Administration (RDA) of Korea found the Soyasaponin content in peanut new seedling is 30times higher than that in ungerminated seeds. Maximally 15.4mg Soyasaponin is in 1g peanut new seedling extractive.

RDA proved the preventive and improving effect of the peanut new seedling extractive for osteoporosis by animal cell test; osteocyte damage ability is restricted for 3.5 times, and bone formation ability is improved 6.1times. Thus, the higher the Soyasaponin content is, the higher the osteocyte activity will be. The seed of peanut new seedling cultivation is the “Xinbaguang” variety in Korea, which is of large grain size, high output and easy cultivation. Test finds the Soyasaponin content is the highest when sprouting for 7~10days and the seedling is about 15cm high.

RDA has applied for patent of “A Production Method of Soyasaponin Substance with Osteoporosis Improvement Function”, and cooperated with enterprises to develop processing food of grains and tea with peanut new seedling extractive as raw materials. The products will be put into market in 2018.

National Academy of Sciences of Korea transferred the patent of peanut new seedling cultivation technology to the company, and the company signed with local growers to plant about 50ha. peanuts.